about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
10.97
0.20
(1.86%)
2.3M
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Replimune Group Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..